Lara Sullivan's Net Worth
$8.77 Million
Who is Lara Sullivan?
Lara Sullivan has an estimated net worth of $8.77 Million. This is based on reported shares across multiple companies, which include Pyxis Oncology, Inc., and REXAHN PHARMACEUTICALS, INC..
SEC CIK
Lara Sullivan's CIK is 0001769457
Past Insider Trading and Trends
2023 was Lara Sullivan's most active year for acquiring shares with 5 total transactions. Lara Sullivan's most active month to acquire stocks was the month of February. 2023 was Lara Sullivan's most active year for disposing of shares, totalling 8 transactions. Lara Sullivan's most active month to dispose stocks was the month of August. 2024 saw Lara Sullivan paying a total of $4,102,856.86 for 1,071,242 shares, this is the most they've acquired in one year. In 2023 Lara Sullivan cashed out on 1,273,586 shares for a total of $474,962.38, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Pyxis Oncology, Inc. (PYXS) Snapshot price: $3.45
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 26
| |||
Form 4
| -0.36% | -8.64K |
$2.10 | -$18,161.10 | 2.4M |
Sep 14 - Sep 18
| |||
Form 4
| -8.10% | -212.66K |
$2.15 | -$456,801.28 | 2.41M |
Sep 11 - Sep 13
| |||
Form 4
| +21.78% | 469.48K |
—
|
—
| 2.63M |
Sep 7
| |||
Form 4
| +48.43% | 703.38K |
—
|
—
| 2.16M |
Mar 24
| |||
Form 4
| +7.05% | 95.68K |
—
|
—
| 1.45M |
Jan 3
| |||
Form 4
| +30.28% | 315.27K |
—
|
—
| 1.36M |
Apr 14
| |||
Form 4
| +248.53% | 742.57K |
—
|
—
| 1.04M |
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
REXAHN PHARMACEUTICALS, INC. (OCUP) Snapshot price: $1.2001
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||